VAERS Explorer
Back to explore

Report #2870318

Received Nov 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
KY
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Expired product administered

Symptom narrative

received expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: received expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-OCT-2025 The pharmacist reported that a patient that received an expired dose of Arexvy. When can we repeat the dose. The batch number was not provided upon follow up with the reporter.